Status:
COMPLETED
Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu
Lead Sponsor:
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Collaborating Sponsors:
Department of Health, Western Australia
Conditions:
Upper Respiratory Tract Infections
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
The aim of the study is to see if lozenges containing a low dose of interferon-alpha can prevent and/or reduce the severity of colds and flu. Starting about 1 month before the expected start of the wi...
Eligibility Criteria
Inclusion
- Male or non-pregnant female
- Females of child-bearing potential must practice a medically accepted form of birth control
Exclusion
- Currently exhibiting an acute upper respiratory tract infection
- history of chronic respiratory disease requiring regular therapy(i.e. COPD, asthma, bronchitis, etc.)
- any condition likely to increase the risk of severe or complicated influenza (i.e. cardiac disease, chronic renal disease, endocrine diseases, including diabetes and/or immunosuppressive therapy)
- any condition requiring regular treatment with antihistamines, analgesics or antipyretics
- known infection with HIV, hepatitis B virus or hepatitis C virus
- any other serious, uncontrolled disease
- any active infections requiring use of antibiotic or antiviral drugs
- non-ambulatory status
- suspected drug or alcohol abuse
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00895947
Start Date
April 1 2009
End Date
March 1 2010
Last Update
September 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Western Australia
Nedlands, Western Australia, Australia, 6009